Infusion of adenosine into the coronary arteries of isolated guinea pig hearts produced a dose-dependent inhibition of cardiac contractile force development elicited by bolus injections of histamine (7.5 x 10~9 mol) or dopamine (1.5 X 10" 8 mol). Threshold concentration of adenosine was 1(T 7 M and maximal inhibition (90%) was obtained at 3 x 10" 5 M. Adenosine in the effective concentration range did not alter Ca 2+ -induced increases in contractile force. The rise in tissue levels of cAMP induced by equieffective doses of histamine (7.5 x 10~9 mol) and dopamine (1.5 x 10~8 mol) was inhibited by adenosine (3.5 x 10" 5 M) by about 60%. In a particular membrane preparation of guinea pig ventricles the adenylate cyclase activity stimulated by the histamine (10~5 M) and dopamine (10~4 M) was inhibited in a dose-dependent manner by adenosine. This effect could be reversed by theophylline (5 x 10" 5 M) in a competitive manner. The hormone-insensitive adenylate cyclase of a Lubrol-PX solubilized membrane preparation stimulated by NaF or 5'-guanylylimido-diphosphate (GppNHp) was also inhibited by adenosine (40% and 90% inhibition at 10" 5 M and 10~4 M, respectively). Adenosine did not influence the K m value of the adenylate cyclase for ATP, but markedly lowered V ma x of the enzyme. From additional studies with purine-substituted (7V 8 -methyl-adenosine, JV 6 -phenylisopropyl-adenosine) and ribose-substituted (2'-deoxy-adenosine and arabino-furanosyl-adenine) adenosine analogues, we conclude that adenosine may inhibit the inotropic responses to hormones as well as the adenylate cyclase activity by specifically interacting with at least two different sites associated with the adenylate cyclase.
CARDIAC adenylate cyclase is stimulated by catecholamines Duncan, 1970, Schrader et al., 1977a) , histamine (Josephson et al, 1976) , Klein and Levey, 1971 ) and glucagon (Levey and Epstein, 1969) and the resulting increases in tissue levels of 3',5'-cyclic AMP cAMP are assumed to be causally related to the inotropic responses to these hormones (for review see Drummond and Severson, 1979) . The functional effects of the hormones result from their primary interaction with a specific membrane-associated receptor site on the outer cell surface (Tsien, 1977) which then initiates the activation of the adenylate cyclase at the inner side of the membrane. The mechanism by which cAMP can trigger transmembrane Ca 2+ movement is not clear, however; it may involve phosphorylation of sarcolemmal proteins by a cAMP-dependent protein kinase (Sulakhe et al., 1976) .
Work from our laboratory indicates that adeno-sine, a physicological breakdown product of adenine nucleotides, can attenuate the inotropic and glycogenolytic effects of catecholamines in the isolated perfused guinea pig heart (Schrader et al., 1977a) This effect, which recently also was demonstrated for the rat heart (Dobson, 1978) , is probably mediated by a direct action of adenosine on sarcolemmal adenylate cyclase (Schrader et al., 1977a) . However, no information is available as to whether adenosine can antagonize increases in cardiac contractility and adenylate cyclase activity initiated by substances other than catecholamines (e.g., glucagon, histamine). Furthermore, it has not been determined whether, in the heart as in other tissues, different adenosine-sensitive sites can be distinguished using purine-and ribose-modified adenosine derivatives (Londos et al., 1978) . The purpose of the present study was to clarify whether adenosine and some selected analogues can antagonize the inotropic and metabolic actions of histamine and dopamine which are known to act via different sarcolemmal receptor sites (Klein and Levey, 1971 ). In addition, the influence of adenosine and its derivatives on a particulate preparation of cardiac plasma membranes stimulated by histamine and dopamine as well as on a hormone-insensitive, solubilized adenylate cyclase preparation was investigated.
Methods [8] [9] [10] [11] [12] [13] [14] C]-Adenosine 5'-triphosphate, tetrasodium salt (specific activity 51.9 mCi/mmol) was obtained from New England Nuclear. Theophylline and papaverine hydrochloride were obtained from Merck. Isoproterenol was purchased from Schuchard-Merck and histamine from Serva. Dopamine and reserpine were obtained from Sigma. The radioisotope dilution test kit for determination of cAMP, all purine compounds, creatine phosphate and creatine kinase (EC 2.7.3.2) were obtained from Boehringer Mannheim. Silica gel thin layer plates (Polygram SIL G/UV254) were purchased from Macherey and Nagel. Lubrol-PX was a gift by Dr. Pfeufer, Wiirzburg, and compound D 600 was kindly supplied by Knoll AG. iV 6 -Methyl-adenosine, 2'-deoxyadenosine, and arabinofuranosyl-adenine were from Sigma. iV 6 -Phenylisopropyl-adenosine was purchased from Boehringer Mannheim. All other substances used were of analytical reagent grade.
Isolated Guinea Pig Hearts
In all experiments, isolated hearts were perfused according to the Langendorff technique with constant flow (12 ml/min) by use of a roller pump. The perfusate consisted of a modified Krebs-Henseleit solution gassed with 95% O 2 -5% CO2 as recently described (Schrader et al., 1977a) . All substances to be tested were either infused (<80 jul/min) for the time indicated in figures, or injected as a bolus (10 jul) directly into the perfusion stream about 2 cm above the orifice of the coronary arteries. In special experiments, guinea pigs were pretreated with reserpine (5 mg/kg, dissolved in 20% ascorbic acid) 24 hours before isolation of the hearts.
Analytical Procedures
Isolated hearts still attached to the perfusion system were frozen between aluminum blocks precooled in liquid nitrogen. Tissue extraction with 0.5 N perchloric acid, neutralization of the extracts, and quantification of cAMP by the radioisotope dilution assay of Gilman were performed as described elsewhere (Gilman, 1970; Schrader et al., 1977a) .
A sarcolemmal prepartion of guinea pig ventricles was prepared as reported by Drummond et al. (1970) with the modifications described (Schrader et al., 1977a) . Protein was determined according to the method of Lowry.
Solubilization of adenylate cyclase: After the final centrifugation step in the course of preparation of particulate membranes, the pellet was diluted in a solution containing Tris-HCl, 10 nun, pH 7.5; MgCl2, 1 mM; /?-mercaptoethanol, 1 mM; and Lubrol-PX, 0.5% (final protein concentration: 15 mg/ ml) and homogenized for 1 minute at 4°C in a homogenizer (Braun-Melsungen) using a Teflon pestle (10 up-and-down strokes, 1500 rpm). The homogenate was gently stirred for 20 minutes at 4°C and then centrifuged in a Beckman ultracentrifuge (model L 5.65) at 105,000 g for 1 hour. The supernatant contained solubilized adenylate cyclase and was assayed immediately. Enzyme activity was found to remain constant for 2 hours, and gradually declined thereafter.
Adenylate cyclase activity was determined by measuring the conversion of [ 14 C]ATP to [ 14 C] cAMP, employing thin layer chromatography for the isolation of labeled [ 14 C]cAMP (Shimizu et al., 1969 ). The assay system (final volume: 150 pil) contained Tris-HCl, 40 mM, pH 7.5; MgSO 4) 15mM; EGTA, 0.1 mM; [8-14 C]ATP, 0.4 mM (specific activity 3.2 mCi/mmol); papaverine hydrochloride, 1 HIM; creatine phosphate, 10 mM; and creatine kinase (3 U/150 jtd). Hormones and all other compounds were added at final concentrations as indicated in Results. The reaction was started by addition of membrane protein (500-600 jug/ml), which was preincubated for 5 minutes at 0°C with the substances to be tested. After an incubation period of 10 minutes, reaction was terminated by heating the tubes for 3 minutes (95°C).
Radiaoactivity measurements were performed as previously described (Schrader et al., 1977a) . Statistical analysis of the data used the Student's unpaired f-test, and differences were considered significant if P < 0.05.
Results

Interaction of Adenosine and Adenosine Analogues with Inotropic Effects of Histamine, Dopamine, and Isoproterenol
Adenosine proved to be an effective inhibitor of the inotropic action of histamine and dopamine. As can be seen from a representative experiment shown in Figure 1 , bolus injections of histamine (7.5
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FIGURE 1 Effects of adenosine and theophylline on the changes in some hemodynamic parameters caused by bolus injections of histamine (7.5 X 10' 9 mol). Hearts were electrically paced (8 V, 3 msec), because adenosine at the given concentration induces A V block. Constant flow perfusion 12 ml/min. Fig. 1 ) the area underneath the rise of dP/dt mî nduced by bolus injection (10 \d) of histamine (7.5 X 10~% mol) or dopamine (1.5 X 10' s mol) in the absence (controls) and presence of increasing amounts of adenosine. X 10 M mol) elicited transient increases of intraventricular pressure and dp/dtm ax . Infusion of adenosine caused a marked fall in perfusion pressure, but did not alter basal contractile force of the heart. However, the inotropic response to histamine became significantly attenuated by adenosine. When theophylline (2.8 X 10~5 M) was administered, together with adenosine, contractile force development upon injection of histamine was restored almost to control values. Similar results were obtained with dopamine (1.5 X 10~8 mol).
The inhibitory influence of adenosine on the histamine-and dopamine-induced increases in cardiac contractile force proved to be dose-dependent. As is evident from Figure 2A , the inhibition of dP/ dt max by adenosine started at a concentration of 1(T 7 M and reached a maximum of about 90% at 3 X 10" 5 M adenosine. Quantitatively similar values have been reported for the isoproterenol-stimulated heart (Schrader et al., 1977a) .
In a second series of experiments, the effects of several adenosine analogues on cardiac contractile force development stimulated by isoproterenol were investigated. As is evident from Table 1, 2'-deoxyadenosine and arabinofuranosyl-adenine-derivatives differing in the ribose moiety from the adenosine molecule-were either ineffective or only weak inhibitors. In contrast, analogues substituted at the purine moiety, iV 6 -methyl-adenosine and N ephenylisopropyl-adenosine, exhibited marked inhibitory effects. iV 6 -Phenylisopropyl-adenosine proved to be even more effective than adenosine, whereas the potency of 7V 6 -methyl-adenosine was similar to that of adenosine.
Effect to Adenosine and D 600 on Ca 2+ -and Dopamine-induced Increases of Contractile Force
To elucidate further the mechanism of action of adenosine, its effect was examined under the conditions of increased cardiac contractile force due to an elevation of extracellular Ca 2+ concentration. To exclude interferences resulting from the release of endogenous catecholamines, these studies were performed on hearts isolated from reserpinized guinea pigs. Panal A of Figure 3 demonstrates that adenosine (1.7 X 10~5 M) had no significant effect when dP/dt was augmented by raising extracellular Ca 2+ concentration from 1.25 to 2.5 mM. In contrast, adenosine in the same concentration completely blocked an increase in contractile force development elicited by an equieffective dose of dopamine (2.9 X 10" 6 M) ( Fig. 3, panel B ). The action of adenosine proved to be rapid in onset and fully reversible within 1 minute after cessation of the adenosine infusion. Figure 3 also shows results of experiments with compound D 600 (-isopropyl-d-(N-methyl-iV-homoveratryl)-y-aminopropyl-3, 4, 5trimethoxy-phenylacetonitrile), a well-known inhibitor of transmembranal Ca 2+ -influx (Fleckenstein, 1977) . It is evident that D 600 (3.9 X 10" 8 M) completely antagonized the enhancement of contractile force development induced by both Ca 2+ and dopamine. In contrast to the experiments with adenosine, inhibition by D 600 was complete only after 6 minutes, and maximal contractile force development was reached again after 30 minutes. 
Effects of Adenosine on Cardiac Adenylate Cyclase
Myocardial cAMP levels were analyzed 20 seconds after bolus injections of the different inotropic agents (Table 2) . Isoproterenol, histamine, and dopamine in concentrations which were equieffective in augmenting cardiac contractile force, raised cAMP levels to almost the same extent. When adenosine (3.5 X 10" 6 M) was applied, together with isoproterenol, histamine, or dopamine, the increase in cAMP levels was reduced by about 60% in all cases.
Cardiac adenylate cyclase activity was determined in a particulate membrane preparation of guinea pig ventricles. Maximally stimulating doses of histamine (10~5 M) and dopamine (10~4 M) increased basal enzyme activity from 109.6 ± 6.0 (n = 8) to 215.1 ± 4.8 (n = 4) and 207.7 ± 4.9 (n = 4) pmol/min per mg protein, respectively (mean values ± 1 SEM). Adenosine inhibited both histamineand dopamine-stimulated adenylate cyclase. As is shown in figure 2B , the inhibitory effect of adenosine proved to be dose-dependent. The position and steepness of the dose-response curves were similar, although adenosine was slightly more effective in inhibiting the effects of dopamine. Inhibition started at 10~6 M adenosine and was complete at 5 X 10~4 M.
Theophylline antagonized the effects of adenosine on cardiac adenylate cyclase stimulated by dopamine, histamine, or isoproterenol (Table 3) . As is demonstrated in Figure 4 for the isoproterenol- Table 4 ) the influence of adenosine on the Lubrol-PX-solubilized adenylate cyclase preparation was studied. Treatment with Lubrol-PX resulted in a complete loss of sensitivity of the enzyme to histamine, dopamine, and isoproterenol. However, GppNHp (10~4 M) and NaF (8 X 10~3 M) stimulated the adenylate cyclase 5-to 6-fold. Adenosine (10~5 M) inhibited these effects in both cases by about 40%, whereas, at an adenosine concentration of 10~4 M, the effects of GppNHp and NaF were nearly abolished. On the other hand, adenosine (10~4 M) only slightly inhibited basal adenylate cyclase activity (20%). Theophylline (5 X 10~4 M), which antagonized the inhibitory effect of adenosine in the particulate membrane preparation (Table 3) , proved to be without effect on the adenosine-induced inhibition of the solubilized adenylate cyclase.
Data concerning the influence of adenosine analogues on cardiac adenylate cyclase activity in both the particulate and the Lubrol-PX-solubilized membrane preparation are summarized in Table 5 . N 6 -Methyl-adenosine and iV 6 -phenylisopropyladenosine-in contrast to their hemodynamic effectiveness (Table 1) -only weakly inhibited the isoproterenol-stimulated adenylate cyclase activity in the particulate preparation and obviously did not influence at all the GppNHp-stimulated cyclase in the solubilized state. On the other hand both 2'deoxy-adenosine and arabinofuranosyl-adenine strongly inhibited the isoproterenol-and GppNHpinduced increase in the enzyme activity in the particulate as well as in the solubilized adenylate cyclase preparation.
To determine whether the inhibitory action of adenosine on the adenylate cyclase could result from competitive interference with the ATP-converting site of the enzyme, we measured the K mvalue of the NaF-stimulated adenylate cyclase at different adenosine concentrations. Lineweaver-Burk plots (Fig. 5 ) revealed that the apparent K m was constant, whereas V m , of the reaction was lowered with increasing adenosine concentrations.
Discussion
The present study demonstrates that adenosine is a strong inhibitor of the inotropic actions of histamine and dopamine. This finding extends a recent observation from this laboratory according to which adenosine was shown to antagonize the catecholamine-induced increase in cardiac contractile force (Schrader et al., 1977a) . Although cate- VOL. 48, No. 2, FEBRUARY 1981 cholamines and histamine are known to act via different cardiac receptor sites (Josephson et al., 1976; Klein and Levey, 1971) , the potency of adenosine was very similar in all cases. Although adenosine inhibited the contractile effects of histamine, dopamine, and isoproterenol, it did not influence the increase in contractile parameters due to an elevation of extracellular Ca 2+ . It thus appears that adenosine effects contractile force only when it has been increased by hormonal stimuli.
Results similar to those obtained in the present study with ventricular myocardium already have been reported for the K + -depolarized atrial myocardium from guinea pigs (Schrader et al., 1975) . In this preparation, adenosine proved to inhibit the catecholamine-induced action potential which was carried by Ca 2+ ions. Similarly, recently adenosine also was reported to inhibit the isoproterenol-induced increase of contractility in rat atria (Rockhoff and Dobson, 1979) . These effects of adenosine appear to be mediated by adenosine receptors localized at the outer surface of the sarcolemmal membrane, since an adenosine derivative of high molecular weight which is confined to the extracellular space was as effective as adenosine itself (Schrader et al., 1977b) . It should be mentioned that this adenosine derivative also was found to antagonize the inotropic action of catecholamines and histamine on the ventricular myocardium (unpublished observations). Thus, the effects of adenosine on Basal enzyme activity and rates of stimulation were similar to values given in Table 3 . Protein concentration, 80-100 jig/tube; incubation time, 10 minutes. Mean values + 1 SEM. atrial and ventricular myocardium are probably brought about by a specific interaction with "adenosine receptors" located at the surface of the myocardial cell membrane.
Concerning the mechanism of the catecholamineantagonistic action of adenosine, /?-adrenergic stimulation of the heart has been demonstrated to increase the number of functional conductance channels for Ca 2+ in the sarcolemmal membrane (Reuter and Scholz, 1977) . Based on these findings, it is conceivable that adenosine may act by reducing the number of newly formed Ca 2+ channels. However, the existing Ca 2+ conductance appears not to be altered by adenosine, since the nucleoside does not reduce contractile force of ventricular muscle, nor does it influence the augmented force development due to an elevation of the extracellular Ca 2+ concentration (Fig. 3) .
The influence of adenosine on mechanical parameters of heart function was paralleled by an inhibition of the histamine-and dopamine-dependent rise of cAMP levels. This finding is most likely due to an inhibition of the formation of cAMP, since changes of the activity of the membranebound phosphodiesterase could be excluded in previous experiments (Schrader et al., 1977a) . Furthermore, this explanation is supported by our studies on the activity of the adenylate cyclase in a particulate membrane preparation in which adenosine was found to inhibit dose-dependently both the histamine-and dopamine-stimulated enzyme.
Adenosine recently was proposed to modulate adenylate cyclase by two different sites, designated P-and R-site (Londos et al., 1978) . Whereas the Rsite is assumed to be located on the external surface of the cell and accepts only adenosine and its analogues modified at the purine ring, the P-site is considered to be situated at the internal cell surface and accepts, besides adenosine, its ribose-modified derivatives. Binding to the R-site results in either activation or inhibition of adenylate cyclase; binding to the P-site induces only inhibition. The results obtained in the present study, using different purine-and ribose-modified adenosine analogues, appear to be in agreement with this hypothesis. In the intact heart, the R-site analogues iV 6 -methyl-adenosine and 2V 6 -phenylisopropyl-adenosine, inhibited the contractile effects of isoproterenol, probably by interaction with surface-located adenosine receptors. These compounds, however, did not influence adenylate cyclase activity under in vitro conditions. On the other hand, P-site analogues, 2'-deoxy-adenosine and arabinofuranosyl-adenine, which were almost ineffective in the intact heart, inhibited the isoproterenol-stimulated adenylate cyclase in the particulate and detergent-solubilized membrane preparation. These findings are consistent with the idea that different sites for adenosine may be involved in mediating the inhibitory effects of adenosine in the intact heart and on adenylate cyclase. Similar conclusions were drawn recently from studies on the effects of different adenosine analogues on fat cells (Trost and Stock, 1977) and on platelets (Haslam et al., 1978) .
The existence of a separate site of action of adenosine associated with the cardiac adenylate cyclase is further supported by our finding that adenosine inhibited the GppNHp-and NaF-stimulated adenylate cyclase in the solubilized state, in which the individual hormone receptors are destroyed or masked (Lefkowitz, 1975; Levey, 1970) . Also in agreement with this view is the observation that adenosine did not compete with the ATPconverting site of the adenylate cyclase ( Fig. 5 ) and also did not influence binding of /3-receptor antagonists to the particulate membrane preparation (Dr. Krawitz, University of Munich, personal communication).
Demonstration of different adenosine-sensitive sites, discriminated by structure-action relationship in vitro, does not necessarily demonstrate the existence of such receptor sites in vivo. Isolation techniques for cell membranes and separation of the receptor molecule from its surrounding membrane environment by use of detergents may well disturb the conformation and thus the specific characteristics of the binding sites (Maddy and Dunn, 1976) . Whether conformational changes can account for the finding that R-site analogues are effective only in the membrane preparation is not known. On the other hand, it appears possible that the ineffectiveness of the R-site analogues in the intact heart may be due to rapid intracellular metabolic conversion. In this way, no sufficient concentration would be reached at the internal surface of the sarcolemma.
The complexity of the action of adenosine is further emphasized by the fact that, depending on the concentration of GTP and divalent cations in the assay medium, adenosine may induce either stimulation or inhibition of adenylate cyclase (Lon- VOL. 48, No. 2, FEBRUARY 1981 dos and Preston, 1977) . Such alterations in the environment of the adenylate cyclase may account for the contradictory findings in heart slices where adenosine increased cAMP levels and potentiated the action of catecholamines (Huang and Drummond, 1976) , whereas, in the same preparation, adenosine also was reported to inhibit the isoproterenol-induced rise of cAMP (Dobson, 1978) .
Several biological effects of adenosine have been shown to be antagonized by theophylline. In the heart, theophylline was reported to inhibit adenosine-induced coronary dilation in a competitive manner (Biinger et al., 1975) and to antagonize the effects of adenosine on cAMP accumulation in the presence of catecholamines (Schrader et al., 1977a) . In addition, the present study demonstrates that theophylline also competitively inhibits the effects of adenosine in the particulate adenylate cyclase preparation. Whether theophylline produces this effect by competing directly with adenosine for the same receptor site or whether it influences adenosine binding by allosteric mechanisms is not known. In agreement with the latter interpretation is the observation that theophylline was ineffective in a solubilized membrane preparation where adenosine was still inhibitory (Table 4) . Possibly, some membrane component essential for binding of theophylline was destroyed or lost as a consequence of the detergent treatment of the membranes.
Results obtained in a previous study lead us to speculate that adenosine formed by the heart may act as an endogenous negative "feed-back" inhibitor, which limits mechanical and metabolic stimulation of the heart by catecholamines (Schrader et al., 1977a; Dobson, 1978) . In this respect it seems of particular interest that formation and release of adenosine into the coronary effluent perfusate also has been found to be considerably enhanced under the influence of histamine (Wiedmeier and Spell, 1977) . Thus it appears conceivable that endogenously formed adenosine, in addition to its catecholamine antagonistic action, might also attenuate the response of the heart to histamine. Therefore, the action of adenosine seems to be of a more general nature and pertains to such situations in which the cardiac adenylate cyclase is stimulated by isoproterenol, histamine, and dopamine. Apparently the mechanism of action of adenosine is the same in all cases, namely, modulation of a late step in the series of events by which hormones induce activation of the adenylate cyclase.
